首页 > 市场调查报告书 > 基础设施

水处理

海水淡化和缓衝交换市场规模、份额和成长分析（按产品、技术、应用、最终用途和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1898388

海水淡化和缓衝交换市场规模、份额和成长分析（按产品、技术、应用、最终用途和地区划分）—产业预测，2026-2033年

Desalting and Buffer Exchange Market Size, Share, and Growth Analysis, By Product (Cassettes & Cartridges, Membrane Filters), By Technique (Filtration, Chromatography), By Application, By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，海水淡化和缓衝交换市场规模将达到 14.7 亿美元，到 2025 年将达到 16.2 亿美元，到 2033 年将达到 34.8 亿美元，在预测期（2026-2033 年）内，复合年增长率为 10%。

受生物製药研发和生产需求成长的推动，全球海水淡化和缓衝液交换市场正经历显着成长。蛋白质纯化技术的日益普及和生物製药的广泛应用是推动这一趋势的关键因素。层析法和过滤技术的创新也促进了市场扩张。製药和生物技术产业是主要的终端用户，对整体成长起着重要作用。儘管北美和欧洲凭藉其完善的研究基础设施目前在市场应用方面处于领先地位，但亚太地区的新兴经济体展现出巨大的成长潜力。关键趋势包括海水淡化技术的不断进步，这些技术旨在解决缓衝液交换过程中的扩充性和永续性挑战。未来发展很可能受到主要产业参与者之间策略联盟和伙伴关係的影响。

海水淡化和缓衝剂交换市场驱动因素

生物製药（例如单株抗体和治疗性蛋白质）需求的不断增长是推动市场发展的主要动力。生物製药产业的持续成长带动了对高效纯化方法的需求，凸显了海水淡化和缓衝液交换製程的重要性。这些技术对于生产高品质生物製药产品至关重要，并能满足业界对先进纯化解决方案的需求。此外，人们日益关注如何生产疗效和安全性更高的生物製药，这持续推动对这些创新纯化策略的兴趣，最终促进了海水淡化和缓衝液交换市场的进步和扩张。

海水淡化和缓衝剂交换市场限制

海水淡化和缓衝液交换市场面临的一大挑战是先进技术实施的高昂前期成本。实施和整合这些复杂系统所需的大量资金投入可能构成重大障碍，尤其对于预算有限的小规模实验室和机构而言更是如此。这种资金障碍会限制创新解决方案的取得和应用，最终阻碍研发活动的营运效率和效益。因此，这些技术的高成本会阻碍市场的整体成长和普及，进而影响整个产业的竞争力。

海水淡化和缓衝交换市场趋势

在海水淡化和缓衝液交换市场，自动化和高通量技术的应用已成为一个显着趋势。这些技术透过减少人工操作和缩短处理时间，提高了营运效率。这项变革在生物製药领域尤其重要，因为该领域需要处理大量的样品，快速且有效率的处理至关重要。此外，随着对永续性的日益重视，许多公司正致力于在海水淡化和缓衝液交换技术中采用可生物降解材料和环保方法。对自动化和环境责任的双重关注，体现了该行业对创新和永续性的承诺，并将进一步推动市场成长和发展。

Thermo Fisher Scientific（USA）
Sartorius AG（Germany）
Merck KGaA（Germany）
Danaher Corporation（USA）
Agilent Technologies（USA）
Repligen Corporation（USA）
GE HealthCare Technologies（USA）
Bio-Works Technologies（Sweden）
Norgen Biotek Corp（Canada）
Bio-Rad Laboratories（USA）
Avantor, Inc.（USA）
Pall Corporation（USA）
Waters Corporation（USA）
EMD Millipore（USA）
Tosoh Bioscience（Japan）
PerkinElmer（USA）
Shimadzu Corporation（Japan）
Lonza Group（Switzerland）

结论与建议

简介目录

Product Code: SQMIG30B2031

Desalting and Buffer Exchange Market size was valued at USD 1.47 Billion in 2024 and is poised to grow from USD 1.62 Billion in 2025 to USD 3.48 Billion by 2033, growing at a CAGR of 10% during the forecast period (2026-2033).

The global market for Desalting and Buffer Exchange is experiencing significant growth, fueled by the increasing demand in biopharmaceutical research and production. Rising awareness around protein purification techniques and the expanding use of biologics are pivotal factors driving this trend. Technological innovations in chromatography and filtration methods further contribute to market expansion. The pharmaceutical and biotechnology sectors serve as primary end-users, influencing overall growth. While North America and Europe currently lead in adoption due to established research infrastructures, emerging economies within the Asia-Pacific region showcase substantial growth potential. Key trends include ongoing advancements in desalting technologies that address scalability and sustainability challenges in buffer exchange processes. Future developments will likely be shaped by strategic collaborations and partnerships among key industry players.

Top-down and bottom-up approaches were used to estimate and validate the size of the Desalting and Buffer Exchange market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Desalting and Buffer Exchange Market Segments Analysis

Global Desalting and Buffer Exchange Market is segmented by Product, Technique, Application, End-Use and region. Based on Product, the market is segmented into Cassettes & Cartridges, Membrane Filters, Spin Columns, Filter Plates, Kits and Other Consumables. Based on Technique, the market is segmented into Filtration, Chromatography and Precipitation. Based on Application, the market is segmented into Bioprocess Applications, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Diagnostic Applications. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Desalting and Buffer Exchange Market

The increasing demand for biopharmaceuticals, such as monoclonal antibodies and therapeutic proteins, significantly propels the market forward. As the biopharmaceutical sector experiences continuous growth, the requirement for efficient purification methods rises, highlighting the importance of desalting and buffer exchange processes. These techniques are essential in producing high-quality biopharmaceutical products, responding to the industry's need for enhanced purification solutions. Furthermore, the emphasis on producing biologics with improved efficacy and safety contributes to the sustained interest in these innovative purification strategies, ultimately driving advancements and expansions within the desalting and buffer exchange market.

Restraints in the Desalting and Buffer Exchange Market

A major challenge facing the desalting and buffer exchange market is the high initial costs associated with adopting advanced technologies. The substantial financial investment required for acquiring and integrating such sophisticated systems can pose significant hurdles, particularly for smaller research laboratories and organizations with constrained budgets. This financial barrier can limit their ability to access and utilize these innovative solutions, ultimately impeding their operational efficiency and effectiveness in research and development activities. As a result, the high expenses tied to these technologies may hinder broader market growth and adoption, affecting the overall competitiveness within the industry.

Market Trends of the Desalting and Buffer Exchange Market

The desalting and buffer exchange market is experiencing a significant trend towards the adoption of automated and high-throughput technologies, which enhance operational efficiency by reducing manual labor and minimizing processing times. This shift is particularly vital for the biopharmaceutical sector, where rapid and effective processing is essential given the high volumes involved. Additionally, there is a growing emphasis on sustainability, with many companies focusing on biodegradable materials and greener practices in their desalting and buffer exchange technologies. This dual emphasis on automation and environmental responsibility reflects an industry's commitment to innovation and sustainability, driving further growth and development in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Desalting and Buffer Exchange Market Size by Product & CAGR (2026-2033)

Market Overview
Cassettes & Cartridges
Membrane Filters
Spin Columns
Filter Plates
Kits
Other Consumables

Global Desalting and Buffer Exchange Market Size by Technique & CAGR (2026-2033)

Market Overview
Filtration
Chromatography
Precipitation

Global Desalting and Buffer Exchange Market Size by Application & CAGR (2026-2033)

Market Overview
Bioprocess Applications
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Applications

Global Desalting and Buffer Exchange Market Size by End-Use & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Diagnostic Laboratories

Global Desalting and Buffer Exchange Market Size & CAGR (2026-2033)

North America (Product, Technique, Application, End-Use)
- US
- Canada
Europe (Product, Technique, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technique, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technique, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technique, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Repligen Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Works Technologies (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMD Millipore (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tosoh Bioscience (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments